Biological rationale for patient-specific treatment of breast cancer. Analysis of new data for breast cancer

by R. M. Paltuev
Published 2020-03-01

Biological rationale for a patient-specific approach in the treatment of breast cancer. Clinical value of novel biomarkers of breast cancer

by R. M. Paltuev
Published 2019-09-01

General recommendations for the management of breast cancer (St. Gallen Expert Consensus developed at the 16^thth International Breast Cancer Conference)

by V. F. Semiglazov, R. M. Paltuev, V. V. Semiglazov
Published 2020-03-01

AUTOMATED ANALYSIS OF CELL DENSITY IN BREAST CANCER AS AN ADDITIONAL METHOD OF INCREASING OBJECTIVITY AND ACCURACY OF BREAST CANCER PROGNOSIS

by R. M. Paltuev, A. G. Kudabergenova, V. F. Semiglazov, A. V. Komyakhov
Published 2017-09-01

The role of neoadjuvant chemotherapy of triple-negative breast cancer in St. Petersburg City Clinical Oncological Dispensary

by A. G. Manikhas, R. N. Babeshkin, R. M. Paltuev, G. M. Manikhas
Published 2016-09-01

General St. Gallen-2015 guidelines for the treatment of early breast cancer (adapted by the experts of the Russian Society of Breast Oncologists)

by V. F. Semiglazov, R. M. Paltuev, V. V. Semiglazov, G. A. Dashyan, T. Yu. Semiglazova, P. V. Krivorotko, K. S. Nikolaev
Published 2015-09-01

Correlation of the value of sonoelastography strain ratio with the degree of pathological regression in patients with locally advanced breast cancer undergoing neoadjuvant chemothe...

by E. A. Bus’ko, A. V. Mishchenko, V. V. Semiglazov, P. V. Krivorot’ko, T. Yu. Semiglazova, R. M. Paltuev, A. S. Petrova, A. V. Komyakhov, V. F. Semiglazov
Published 2017-02-01

New prospects in the use of Kadcyla® in breast cancer

by G. A. Dashyan, V. F. Semiglazov, P. V. Krivorot’ko, R. M. Paltuev, E. E. Topuzov, T. Yu. Semiglazova, E. K. Zhil’tsova, R. V. Donskikh, T. T. Tabagua, V. S. Apollonova
Published 2015-11-01

Novyy vzglyad na neoad\"yuvantnuyu khimioterapiyu raka molochnoy zhelezy (rol' navel'bina)

by V F Semiglazov, A S Arzumanov, A A Bozhok, R M Paltuev, E E Topuzov, V V Semiglazov, A A Klettsel', K Sh Nurgaziev, O A Ivanova, S G Petrovskiy
Published 2003-09-01

Current approaches to the treatment of HER2‑positive breast cancer with brain metastases

by T.  Yu.  Semiglazova, S.  M.  Sharashenidze, S.  N.  Kerimova, V.   V. Klimenko, A. Yu.  Malygin, G.  A.  Dashyan, R.   M. Paltuev, V.  V.  Semiglazov, P.   V. Krivorotko, S.  N.  Novikov, V.   F. Semiglazov
Published 2021-06-01

New opportunities to improve of duration and quality of life: eribulin in the treatment of patients with advanced breast cancer

by T Yu Semiglazova, V A Klyuge, V V Semiglazov, G M Teletaeva, P V Krivorotko, G A Dashyan, R M Paltuev, E V Tkachenko, R V Donskikh, V F Semiglazov
Published 2016-06-01

Neoadjuvant treatment for breast cancer

by V. F. Semiglazov, V. V. Semiglazov, R. M. Paltuev, G. A. Dashyan, T. Yu. Semiglazova, P. V. Krivorotko, A. V. Komyakhov, Zh. V. Bryantseva, K. S. Nikolaev, D. Ye. Shchedrin, A. M. Yermochenkova
Published 2014-07-01

Role of targeted therapy in the treatment of HER-2-positive breast cancer brain metastases

by G. A. Dashyan, V. F. Semiglazov, P. V. Krivorot’ko, T. Yu. Semiglazova, E. E. Topuzov, R. M. Paltuev, K. Yu. Zernov, V. S. Apollonova, S. S. Ereshchenko, A. V. Petrova, E. K. Zhil’tsova, O. A. Ivanova
Published 2016-06-01

NEOADJUVANT ENDOCRINE THERAPY FOR PATIENTS WITH ESTROGEN-RECEPTOR-POSITIVE BREAST CANCER

by V. F. Semiglazov, V. V. Semiglazov, G. A. Dashyan, P. V. Krivorotko, V. G. Ivanov, E. K. Zhiltsova, R. M. Paltuev, L. M. Bershtein, T. Yu. Semiglazova, S. S. Yerechshenko, V. V. Klimenko, V. S. Apollonova, A. V. Komyahov, A. A. Bessonov
Published 2018-07-01

NEW ADVANCES IN THE TREATMENT OF BREAST CANCER: THE ROLE EPOTHILONES

by T. Y. SEMIGLAZOVA, V. A. KLYUGE, E. A. KOROBEYNIKOVA, P. V. KRIVOROTKO, R. M. PALTUEV, G. M. TELETAEVA, D. H. LATIPOVA, V. V. KLIMENKO, E. V. TACHENKO, A. V. Novik, A. I. SEMENOVA, V. V. SEMIGLAZOV, S. A. PROTSENKO, V. F. SEMIGLAZOV
Published 2017-06-01